14-day Premium Trial Subscription Try For FreeTry Free
NYSE:SYN
Delisted

Synthetics Biologics Inc Stock Price (Quote)

New York Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.91
+0.0050 (+0.556%)
At Close: Jan 27, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.390 $0.98 Friday, 27th Jan 2023 SYN stock ended at $0.91. This is 0.556% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 8.99% from a day low at $0.89 to a day high of $0.97.
90 days $0.390 $0.98
52 weeks $0.152 $1.90

Historical Synthetics Biologics Inc prices

Date Open High Low Close Volume
Jul 29, 2022 $1.50 $1.50 $1.42 $1.44 119 341
Jul 28, 2022 $1.45 $1.49 $1.40 $1.42 81 408
Jul 27, 2022 $1.38 $1.49 $1.36 $1.47 367 064
Jul 26, 2022 $1.50 $1.54 $1.38 $1.38 206 774
Jul 25, 2022 $1.49 $1.55 $1.46 $1.50 189 618
Jul 22, 2022 $0.156 $0.165 $0.153 $0.155 1 940 570
Jul 21, 2022 $0.180 $0.180 $0.152 $0.160 4 925 593
Jul 20, 2022 $0.167 $0.183 $0.164 $0.170 4 310 941
Jul 19, 2022 $0.170 $0.175 $0.161 $0.163 1 150 137
Jul 18, 2022 $0.179 $0.179 $0.165 $0.167 2 337 854
Jul 15, 2022 $0.200 $0.200 $0.152 $0.163 8 954 514
Jul 14, 2022 $0.233 $0.239 $0.228 $0.233 291 926
Jul 13, 2022 $0.230 $0.240 $0.223 $0.227 706 606
Jul 12, 2022 $0.240 $0.245 $0.224 $0.238 411 150
Jul 11, 2022 $0.237 $0.250 $0.226 $0.242 854 083
Jul 08, 2022 $0.238 $0.238 $0.224 $0.238 352 644
Jul 07, 2022 $0.220 $0.230 $0.219 $0.230 622 439
Jul 06, 2022 $0.221 $0.230 $0.220 $0.220 365 684
Jul 05, 2022 $0.238 $0.238 $0.215 $0.226 862 850
Jul 01, 2022 $0.213 $0.238 $0.200 $0.230 1 540 150
Jun 30, 2022 $0.200 $0.219 $0.191 $0.213 909 476
Jun 29, 2022 $0.207 $0.220 $0.195 $0.206 2 303 416
Jun 28, 2022 $0.198 $0.208 $0.196 $0.200 711 073
Jun 27, 2022 $0.215 $0.215 $0.190 $0.195 471 243
Jun 24, 2022 $0.191 $0.195 $0.190 $0.194 451 927
Click to get the best stock tips daily for free!

About Synthetics Biologics Inc

Synthetics Biologics Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile infection (CDI), overgrowth of pathogenic organisms, the emergence of antimicrobial resistance (AMR), ... SYN Profile

Golden Star

Ticker Date Change Price
BSCQ Apr 30 0.393% $19.09
EQC Apr 30 1.76% $18.72
HRB Apr 30 1.69% $47.23
REG Apr 30 1.35% $59.22
INGR Apr 30 0.576% $114.59
BSJP Apr 29 0.175% $22.91
LYG Apr 29 0.781% $2.56
ORA Apr 29 3.46% $64.48
DHT Apr 24 4.34% $11.28
LPLA Apr 19 2.62% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT